Impact of a Program for Rapid Diagnosis and Treatment of Lung Cancer on Hospital Care Delay and Tumor Stage

Globocan 2012. International Agency for Research on Cancer, Lyon, France, 2012. Available a: http://globocan.iarc.fr/factsheet.asp. Accessed December 2013.

De Angelis R. , Sant M. , Coleman M.P. , Francisci S. , Baili P. , Pierannunzio D. , Trama A. , Visser O. , Brenner H. , Ardanaz E. , Bielska-Lasota M. , Engholm G. , Nennecke A. , Siesling S. , Berrino F. , Capocaccia R. : Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol, 15: 23–34, 2014.

González-Barcala F.J. , Falagan J.A. , García-Prim J.M. , Valdes L. , Carreira J.M. , Puga A. , García-Sanz M.T. , Antón D. , Canive J.C. , Pose A. , López-López R. : An sist Sanit Navar, 36: 217–27, 2013.

CG121 Lung cancer: full guideline. National Collaborating Centre for Cancer, Wales, April 2011.

Howlader N. , Noone A.M. , Krapcho M. , Neyman N. , Aminou R. , Waldron W. , Altekruse S.F. , Kosary C.L. , Ruhl J. , Tatalovich Z. , Cho H. , Mariotto A. , Eisner M.P. , Lewis D.R. , Chen H.S. , Feuer E.J. , Cronin K.A. , Edwards B.K. (Eds): SEER Cancer statistics review, 1975–2008. National Cancer Institute, Bethesda, MD, 2011. Available at: http://seer.cancer.gov/csr/1975_2008/

Berrino F. , De Angelis R. , Sant M. , Rosso S. , Bielska-Lasota M. , Coebergh J.W. , Santaquilani M. ; EUROCARE Working Group: Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–1999: results of the EUROCARE-4 study. Lancet Oncol, 8: 773–783, 2007.

Richards M.A. : The size of the prize for earlier diagnosis of cancer in England. Br J Cancer, 101: S125–129, 2009.

NHS Executive: The NHS cancer plan. NHS Executive, London, 2000.

Association of Canadian Academic Healthcare Organizations: “Wait” Watchers… weighing in on wait time initiatives across ACAHO members. Ottawa, March 2005.

Cancer Control Taskforce: The New Zealand Cancer Control Strategy Action Plan 2005–2010. Ministry of Health, Wellington, 2005. Available at: http://www.health.govt.nz/publications/new-zealand-cancer-control-strategy-action-plan-2005–2010. Accessed December 2011.

Ministerio de Sanidad y Consumo: Estrategia en cáncer del Sistema Nacional de Salud. Ministerio de Sanidad y Consumo, Madrid, 2006.

Maguire A. , Porta M. , Malats N. , Gallén M. , Piñol J.L. , Fernandez E. : Cancer survival and the duration of symptoms. An analysis of possible forms of the risk function. Eur J Cancer, 30A, 785–792, 1994.

Bozcuk H. , Martin C. : Does treatment delay affect survival in non-small cell lung cancer? A retrospective analysis from a single UK centre. Lung Cancer, 34: 243–252, 2001.

Pita-Fernández S. , Montero-Martinez C. , Pértega-Diaz S. , Verea-Hernando H. : Relationship between delayed diagnosis and the degree of invasion and survival in lung cancer. J Clin Epidemiol, 56: 820–825, 2003.

Annakkaya A. , Arbak P. , Balbay O. , Bilgin C. , Erbas M. , Bulut I. : Effect of symptom-to-treatment interval on prognosis in lung cancer. Tumori, 93: 61–67, 2007.

Myrdal G. , Lambe M. , Hillerdal G. , Lamberg K. , Agustsson T. , Ståhle E. : Effect of delays on prognosis in patients with nonsmall cell lung cancer. Thorax, 59: 45–49, 2004.

Salomaa E. , Sällinen S. , Hiekkanen H. , Liippo K. : Delays in the diagnosis and treatment of lung cancer. Chest, 128: 2282–2288, 2005.

Bronchogenic Carcinoma Cooperative Group of the Spanish Society of Pneumology and Thoracic Surgery: Influence of delays on survival in the surgical treatment of bronchogenic carcinoma. Lung Cancer, 36: 59–63, 2002.

Cañizares Carretero M.A. , Rivo Vázquez J.E. , Blanco Ramos M. , Toscano Novella A. : García Fontán EMInfluence of delay of surgery on the survival of patients with bronchogenic carcinoma. Arch Bronconeumol, 43: 165–170, 2007.

Christensen E.D. , Harvald T. , Jendresen M. , Aggestrup S. , Petterson G. : The impact of delayed diagnosis of lung cancer on the stage at the time of operation. Eur J Cardiothorac Surg, 12: 880–884, 1997.

González-Barcala F.J. , Falagan J.A. , Garcia-Prim J.M. , Valdes L. , Carreira J.M. , Puga A. , Martín-Lancharro P.M. , Garcia-Sanz M.T. , Anton-Sanmartín D. , Canive-Gomez J.C. , Pose-Reino A. , Lopez-Lopez R. : Timeliness of care and prognosis in patients with lung cancer. Ir J Med Sci, 183: 383–390, 2014.

Yorio J.T. , Xie Y. , Yan J. , Gerber D.E. : Lung cancer diagnostic and treatment intervals in the United States. A health care disparity? J Thorac Oncol, 4: 1322–1330, 2009.

Diaconescu R. , Lafond C. , Whittom R. : Treatment delays in non-small cell lung cancer and their prognostic implications. J Thorac Oncol, 6: 1254–1259, 2011.

Canal Salut Càncer (Web site). Generalitat de Catalunya, Barcelona; Updated February 2010 [accessed 16th May 2014]. Programa de diagnòstic ràpid del càncer. Available at: http://www20.gencat.cat/portal/site/cancer/menuitem.6877f76ecea739f796072d10b0c0e1a0?vgnextoid=76863a6349f73210VgnVCM1000000b0c1e0aRCRD&vgnextchannel=76863a6349f73210VgnVCM1000000b0c1e0aRCRD&vgnextfmt=default

CatSalut. Generalitat de Catalunya, Departament de Salut: Instrucció 04/2005. Implantació del Programa de diagnòstic ràpid de càncer primera fase, 2005. [Accessed 16th May 2014]. Available at: http://www20.gencat.cat/portal/site/salut/menuitem.40dd1b31aa3dd6ec3bfd8a10b0c0e1a0/?vgnextoid=b4639221842ba310VgnVCM2000009b0c1e0aRCRD&vgnextchannel=b4639221842ba310VgnVCM2000009b0c1e0aRCRD&vgnextfmt=detall&contentid=fb8c0221970ca310VgnVCM2000009b0c1e0aRCRD

Generalitat de Catalunya, Departament de Salut: Estratègia i prioritats en el càncer a Catalunya. Pla Director d'Oncologia: Objectius 2010. Barcelona: Direcció General de Planificació i Avaluació, Departament de Salut, 2009. [Accessed 16th May 2014]. Available at: http://www20.gencat.cat/docs/cancer/MERY/RECTIFICAT/Pla%20director%202010.pdf

Cook T.D. , Campbell D.T. : Quasi-experiments: nonequivalent control group designs. In: Quasi-experimentation. Design & analysis issues in field settings, pp 98–99, Houghton Mifflin, Boston, MA, 1979.

Buccheri G. , Ferrigno D. : Lung cancer: clinical presentation and specialist referral time. Eur Respir J, 6: 898–904, 2004.

Sánchez de Cos Escuín J. , Miravet Sorribes L. , Abal Arca J. , Núñez Ares A. , Hernández Hernández J. , Castañar Jover A.M. , Muñoz Gutiérrez F.J. , García Arangüena L. , Alonso M.A. , Montero Martínez M.C. , Allende González J. , Sánchez Hernández I. : Estudio multicéntrico epidemiológico-clínico de càncer de pulmón en España (estudio EpicliCP-2003). Arch Bronconeumol, 42: 446–452, 2006.

Montero C. , Rosales M. , Otero I. , Blanco M. , Rodríguez G. , Peterga S. , Pita S. , Verea H. : Cáncer de pulmón en el Área Sanitaria de A Coruña: incidencia, abordaje clínico y supervivencia. Arch Bronconeumol, 39: 209–216, 2003.

Sobin L.H. , Wittekind Ch (Eds): TNM Clasificación de los tumores malignos, 6a ed. International Union Against Cancer. Pulso Ediciones, Washington, DC, 2002.

Hansen R. , Vedsted P. , Sokolowski I. , Søndergaard J. , Olesen F. : Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res, 11; 284, 2011.

Divisió d'Avaluació de Serveis, Pla Director d'Oncologia: Informe del programa de diagnòstic ràpid del càncer a Catalunya. CatSalut, Generalitat de Catalunya. Barcelona, October 2009.

Prades J. , Espinàs J.A. , Font R. , Argimon J.M. , Borràs J.M. : Implementing a cancer fast-track programme between primary and specialised care in Catalonia (Spain): a mixed methods study. Br J Cancer, 105: 753–759, 2011.

Brocken P. , Kiers B.A. , Looijen-Salamon M.G. , Dekhuijzen P.N. , Smits-van der Graaf C. , Peters-Bax L. , de Geus-Oei L.F. , van der Heijden H.F. : Timeliness of lung cancer diagnosis and treatment in a rapid outpatient diagnostic program with combined 18FDG-PET and contrast enhanced CT scanning. Lung Cancer, 75: 336–341, 2012.

Huerto Pérez de Heredia J. , Cebollero Rivas P. , Cascante Rodrigo J.A. , Andrade Vela I. , Pascal Martínez I. , Boldú Mitjans J. , Eguía Astibia V.M. : Evaluation of the use of a rapid diagnostic consultation of lung cáncer. Delay time of diagnosis and therapy. Arch Bronconeumol, 48: 267–273, 2012.

Murray P.V. , O'Brien M.E. , Sayer R. , Cooke N. , Knowles G. , Miller A.C. , Varney V. , Rowell N.P. , Padhani A.R. , MacVicar D. , Norton A. , Ashley S. , Smith I.E. : The pathway study: results of a pilot feasibility study in patients suspected of having lung carcinoma investigated in a conventional chest clinic setting compared to a centralised two-stop pathway. Lung Cancer, 42: 283–290, 2003.

Pérez G. , Borrell C. , Porta M. , Casamitjana M. , Bonfill X. , Bolibar I. , Fernández E. ; INTERCAT Study Group: Interval from diagnosis to treatment onset for six major cancers in Catalonia, Spain. Cancer Detect Prev, 32: 267–275, 2008.

Alsamarai S. , Yao X. , Cain H.C. : The effect of a lung cancer care coordination program on timeliness of care. Clin Lung Cancer, 14: 527–534, 2013.